Literature DB >> 28228541

Cell dynamics in tumour environment after treatments.

Leili Shahriyari1.   

Abstract

Most cancer treatments cause necrotic cell deaths in the tumour microenvironment. Necrotic cells send signals to immune cells to start the wound healing process in the tissue. Therefore, we assume after stopping treatments there is a wound that needs to be healed. We develop a simple computational model to investigate cell dynamics during the wound healing process after treatments. The model predicts that the involvement of high-fitness cancer cells in the wound healing leads to fast relapse, and cancer cells outside of the wound can cause a slow recurrence of the tumour. Therefore, the absence of relapse after treatments may imply a slow-developing tumour that might not reach an observable size in the patients' lifetime. Additionally, the model indicates that the location of remaining cancer cells after treatments is an important factor in the recurrence time. The fastest recurrence happens when high-fitness cancer cells remain inside of the wound. However, the longest time to recurrence corresponds to cancer cells located outside of the wound. Note that this model is the first attempt to study cell dynamics in the wound healing process after cancer treatments, and it has some limitations that might influence the results. Experiments are needed to validate the results.
© 2017 The Author(s).

Entities:  

Keywords:  cancer; cancer treatments; cell dynamics; stochastic processes; time to recurrence; wound healing process

Mesh:

Year:  2017        PMID: 28228541      PMCID: PMC5332584          DOI: 10.1098/rsif.2016.0977

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  31 in total

Review 1.  Port site metastases.

Authors:  Myriam J Curet
Journal:  Am J Surg       Date:  2004-06       Impact factor: 2.565

2.  Traveling wave model to interpret a wound-healing cell migration assay for human peritoneal mesothelial cells.

Authors:  Philip K Maini; D L Sean McElwain; David I Leavesley
Journal:  Tissue Eng       Date:  2004 Mar-Apr

3.  Gasless laparoscopy may reduce the risk of port-site metastases following laparascopic tumor surgery.

Authors:  D I Watson; G Mathew; T Ellis; C F Baigrie; A M Rofe; G G Jamieson
Journal:  Arch Surg       Date:  1997-02

4.  A mathematical model for fibro-proliferative wound healing disorders.

Authors:  L Olsen; J A Sherratt; P K Maini
Journal:  Bull Math Biol       Date:  1996-07       Impact factor: 1.758

5.  Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients.

Authors:  S Braun; C Kentenich; W Janni; F Hepp; J de Waal; F Willgeroth; H Sommer; K Pantel
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

6.  Toward decoding the principles of cancer metastasis circuits.

Authors:  Mingyang Lu; Mohit Kumar Jolly; Jose' Onuchic; Eshel Ben-Jacob
Journal:  Cancer Res       Date:  2014-09-01       Impact factor: 12.701

Review 7.  The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy.

Authors:  Lionel Apetoh; François Ghiringhelli; Antoine Tesniere; Alfredo Criollo; Carla Ortiz; Rosette Lidereau; Christophe Mariette; Nathalie Chaput; Jean-Paul Mira; Suzette Delaloge; Fabrice André; Thomas Tursz; Guido Kroemer; Laurence Zitvogel
Journal:  Immunol Rev       Date:  2007-12       Impact factor: 12.988

8.  Effect of dedifferentiation on time to mutation acquisition in stem cell-driven cancers.

Authors:  Alexandra Jilkine; Ryan N Gutenkunst
Journal:  PLoS Comput Biol       Date:  2014-03-06       Impact factor: 4.475

9.  Symmetric vs. asymmetric stem cell divisions: an adaptation against cancer?

Authors:  Leili Shahriyari; Natalia L Komarova
Journal:  PLoS One       Date:  2013-10-29       Impact factor: 3.240

10.  Tumour control probability in cancer stem cells hypothesis.

Authors:  Andrew Dhawan; Mohammad Kohandel; Richard Hill; Sivabal Sivaloganathan
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

View more
  7 in total

1.  A PDE Model of Breast Tumor Progression in MMTV-PyMT Mice.

Authors:  Navid Mohammad Mirzaei; Zuzana Tatarova; Wenrui Hao; Navid Changizi; Alireza Asadpoure; Ioannis K Zervantonakis; Yu Hu; Young Hwan Chang; Leili Shahriyari
Journal:  J Pers Med       Date:  2022-05-17

2.  The role of backward cell migration in two-hit mutants' production in the stem cell niche.

Authors:  Audrey Bollas; Leili Shahriyari
Journal:  PLoS One       Date:  2017-09-20       Impact factor: 3.240

3.  Data Driven Mathematical Model of Colon Cancer Progression.

Authors:  Arkadz Kirshtein; Shaya Akbarinejad; Wenrui Hao; Trang Le; Sumeyye Su; Rachel A Aronow; Leili Shahriyari
Journal:  J Clin Med       Date:  2020-12-05       Impact factor: 4.241

4.  A Mathematical Model of Breast Tumor Progression Based on Immune Infiltration.

Authors:  Navid Mohammad Mirzaei; Sumeyye Su; Dilruba Sofia; Maura Hegarty; Mohamed H Abdel-Rahman; Alireza Asadpoure; Colleen M Cebulla; Young Hwan Chang; Wenrui Hao; Pamela R Jackson; Adrian V Lee; Daniel G Stover; Zuzana Tatarova; Ioannis K Zervantonakis; Leili Shahriyari
Journal:  J Pers Med       Date:  2021-10-15

5.  Investigating key cell types and molecules dynamics in PyMT mice model of breast cancer through a mathematical model.

Authors:  Navid Mohammad Mirzaei; Navid Changizi; Alireza Asadpoure; Sumeyye Su; Dilruba Sofia; Zuzana Tatarova; Ioannis K Zervantonakis; Young Hwan Chang; Leili Shahriyari
Journal:  PLoS Comput Biol       Date:  2022-03-16       Impact factor: 4.475

6.  Data Driven Mathematical Model of FOLFIRI Treatment for Colon Cancer.

Authors:  Aparajita Budithi; Sumeyye Su; Arkadz Kirshtein; Leili Shahriyari
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

7.  Data-Driven Mathematical Model of Osteosarcoma.

Authors:  Trang Le; Sumeyye Su; Arkadz Kirshtein; Leili Shahriyari
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.